OpenAI’s GPT-3 Reported as Unviable in Medical Tasks by Healthcare Firm
The French digital care company, Nabla, in researching GPT-3’s capabilities for medical documentation, diagnosis support, and treatment recommendation, found its inconsistency and lack of scientific and medical expertise unviable and risky in healthcare applications. This incident has been downgraded to an issue as it does not meet current ingestion criteria.
- Date it happened
- 2020-10-27
- Organisation involved
- none
This incident was imported from AI Incident Database and is used under CC BY-SA 4.0. Our additions to it — the structured fields, the translation, the checks against other reports — are published under the same licence.
This is a record of what was reported, not a finding that anyone broke the law. If it names your organisation and you believe it is wrong, the corrections process is free and open to everyone.